(Update) Acalabrutinib in CLL and MCL
Acalabrutinib
Zanubrutinib
Update Venetoclax in CLL
Obinutuzumab
CLL Society
NCCN COVID-19 Resources Page
Cancer.gov
NCCN Guidelines for Patients for CLL